Search for: "SCHERING-PLOUGH" Results 61 - 80 of 404
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Jul 2012, 1:18 pm by Jeffrey May
The appellate court decided that wholesalers and retailers who purchased a brand-name sustained-release potassium chloride supplement (K-Dur) used to treat high blood pressure could proceed with an antitrust challenge  to patent infringement litigation settlement agreements between Schering-Plough Corporation — the manufacturer of K-Dur — and generic drug companies. [read post]
16 Jul 2012, 1:02 pm
"Schering-Plough's K-Dur Pay-For-Delay Ruling Reversed": Bloomberg News has this report on a ruling that the U.S. [read post]
30 May 2012, 1:37 pm by Peter Rost
BIOGRAPHY AND CV CONTACT INFORMATION CLIENT LISTEXPERT WITNESS SERVICESMEDIACONGRESS LETTER ON BEHALF OF DR. [read post]
25 May 2012, 8:59 am by John J. Sullivan
”  Id. at *8 (citing Schering--Plough Healthcare Prods., Inc. v. [read post]
25 Apr 2012, 1:56 pm by Jeffrey May
The FTC’s brief urges the Third Circuit to reverse a decision of the federal district court in New Jersey granting summary judgment ((CCH) 2010-1 Trade Cases ¶76,949) in favor of the patent holder, Schering-Plough Corporation, and the alleged infringers–Upsher Smith and ESI. [read post]
22 Apr 2012, 12:07 pm
Organon is part of the Schering-Plough Corporation, which is now owned by Merck. [read post]
12 Apr 2012, 10:56 am by Bexis
Oct. 7, 2009) (“[m]erely alleging that [defendant] marketed the drugs at issue for off-label purposes does not state a claim for fraud”); In re Schering-Plough Corp. [read post]
29 Feb 2012, 11:11 am by Joe Consumer
Oh yeah, back in 2009, we told you that Merck and Schering-Plough agreed to a $41.5 million settlement (without admitting any wrongdoing), resolving 140 claims brought by insurers and consumers "who bought, used, or paid money toward the purchase of Vytorin and Zetia" because the companies buried (for about two years) an unfavorable study that showed the companies' jointly marketed cholesterol drugs, Vytorin and Zetia "were no more effective in unclogging… [read post]
29 Feb 2012, 11:11 am by Joe Consumer
Oh yeah, back in 2009, we told you that Merck and Schering-Plough agreed to a $41.5 million settlement (without admitting any wrongdoing), resolving 140 claims brought by insurers and consumers "who bought, used, or paid money toward the purchase of Vytorin and Zetia" because the companies buried (for about two years) an unfavorable study that showed the companies' jointly marketed cholesterol drugs, Vytorin and Zetia "were no more effective in unclogging… [read post]
18 Feb 2012, 9:11 am
., Organon Pharmaceuticals, Akzo Nobel NV and Schering-Plough Corporation as defendants. [read post]
17 Feb 2012, 11:29 am by Bexis
Schering-Plough Corp., 842 A.2d 174, 177-78 (N.J. [read post]
15 Feb 2012, 7:42 am by Peter Rost
BIOGRAPHY AND CV CONTACT INFORMATION CLIENT LISTEXPERT WITNESS SERVICESMEDIACONGRESS LETTER ON BEHALF OF DR. [read post]
1 Feb 2012, 10:34 am
L'Oreals patent infringement lawsuit is based on evidence that was presented in a prior lawsuit where Schering-Plough Healthcare Products, Inc., which merged with Coppertone-owner Merck, accused Neutrogena, owned by Johnson and Johnson, of infringing on compositions containing the ingredients avobenzone and octocrylene. [read post]